Role of RANKL (TNFSF11)-Dependent Osteopetrosis in the Dental Phenotype of Msx2 Null Mutant Mice
Open Access
- 21 November 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (11), e80054
- https://doi.org/10.1371/journal.pone.0080054
Abstract
The MSX2 homeoprotein is implicated in all aspects of craniofacial skeletal development. During postnatal growth, MSX2 is expressed in all cells involved in mineralized tissue formation and plays a role in their differentiation and function. Msx2 null (Msx2−/−) mice display complex craniofacial skeleton abnormalities with bone and tooth defects. A moderate form osteopetrotic phenotype is observed, along with decreased expression of RANKL (TNFSF11), the main osteoclast-differentiating factor. In order to elucidate the role of such an osteopetrosis in the Msx2−/− mouse dental phenotype, a bone resorption rescue was performed by mating Msx2−/− mice with a transgenic mouse line overexpressing Rank (Tnfrsf11a). Msx2−/− RankTg mice had significant improvement in the molar phenotype, while incisor epithelium defects were exacerbated in the enamel area, with formation of massive osteolytic tumors. Although compensation for RANKL loss of function could have potential as a therapy for osteopetrosis, but in Msx2−/− mice, this approach via RANK overexpression in monocyte-derived lineages, amplified latent epithelial tumor development in the peculiar continuously growing incisor.Keywords
This publication has 27 references indexed in Scilit:
- Inflammatory bone loss: pathogenesis and therapeutic interventionNature Reviews Drug Discovery, 2012
- The new bone biology: Pathologic, molecular, and clinical correlatesAmerican Journal of Medical Genetics Part A, 2006
- A case of amelogenesis imperfecta, cleft lip and palate and polycystic kidney diseaseOrthodontics & Craniofacial Research, 2006
- Interferon-α and -β differentially regulate osteoclastogenesis: Role of differential induction of chemokine CXCL11 expressionProceedings of the National Academy of Sciences of the United States of America, 2005
- Pharmacological Characterization of CXC Chemokine Receptor 3 Ligands and a Small Molecule AntagonistJournal of Pharmacology and Experimental Therapeutics, 2005
- Crosstalk between cancer cells and bone microenvironment in bone metastasisBiochemical and Biophysical Research Communications, 2004
- Trafficking of Natural Killer CellsCurrent Molecular Medicine, 2004
- Human osteoclasts express different CXC chemokines depending on cell culture substrate: molecular and immunocytochemical evidence of high levels of CXCL10 and CXCL12Histochemistry and Cell Biology, 2003
- Comparative Study of MSX-2, DLX-5, and DLX-7 Gene Expression during Early Human Tooth DevelopmentPediatric Research, 1999
- The human homeobox genes MSX-1, MSX-2, and MOX-1 are differentially expressed in the dermis and epidermis in fetal and adult skinDifferentiation, 1997